Skandinaviska Enskilda Banken (SEB)’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,539
| Closed | -$292K | – | 847 |
|
|
2025
Q1 | $292K | Hold |
27,539
| – | – | ﹤0.01% | 726 |
|
|
2024
Q4 | $457K | Hold |
27,539
| – | – | ﹤0.01% | 721 |
|
|
2024
Q3 | $639K | Hold |
27,539
| – | – | ﹤0.01% | 704 |
|
|
2024
Q2 | $671K | Hold |
27,539
| – | – | ﹤0.01% | 670 |
|
|
2024
Q1 | $930K | Buy |
+27,539
| New | +$930K | ﹤0.01% | 664 |
|
|
2022
Q3 | – | Sell |
-6,603
| Closed | -$104K | – | 898 |
|
|
2022
Q2 | $104K | Hold |
6,603
| – | – | ﹤0.01% | 927 |
|
|
2022
Q1 | $178K | Hold |
6,603
| – | – | ﹤0.01% | 893 |
|
|
2021
Q4 | $257K | Hold |
6,603
| – | – | ﹤0.01% | 889 |
|
|
2021
Q3 | $315K | Sell |
6,603
-18,614
| -74% | -$888K | ﹤0.01% | 899 |
|
|
2021
Q2 | $853K | Buy |
+25,217
| New | +$853K | 0.01% | 831 |
|